Clinical trial update: focus on the ONTARGET study

The renin angiotensin system (RAAS) plays an important role in the pathophysiology of cardiovascular (CV) disease. Modulation of RAAS with angiotensin-converting enzyme inhibitors (ACEi), angiotensin receptor blockers (ARB), and aldosterone inhibitors reduces a range of adverse CV outcomes in patien...

Descripción completa

Detalles Bibliográficos
Autor principal: Fitchett, David
Formato: Texto
Lenguaje:English
Publicado: Dove Medical Press 2007
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2350133/
https://www.ncbi.nlm.nih.gov/pubmed/18200809

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2350133/
https://www.ncbi.nlm.nih.gov/pubmed/18200809

Ejemplares similares